COSCIENS Biopharma Inc. (TSX:CSCI)
Canada · Delayed Price · Currency is CAD 8.75
0.00 (0.00%)
Oct 1, 2026, 2:13 PM EST
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of CAD 8.73 million as of October 2, 2026. Its market cap has decreased by -24.55% in one year.
Market Cap
8.73M
Enterprise Value
4.01M
Revenue
12.39M
Ranking
n/a
PE Ratio
0.94
Stock Price
8.75
ChartMarket Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 44.46B to 8.73M, a decrease of -99.98%. That is a compound annual growth rate of -24.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 8.73M | -3.48% |
| Dec 31, 2025 | 9.04M | 30.63% |
| Dec 31, 2024 | 6.92M | -44.54% |
| Dec 29, 2023 | 12.48M | -40.23% |
| Dec 30, 2022 | 20.88M | -62.20% |
| Dec 31, 2021 | 55.24M | 63.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rapid Dose Therapeutics | 13.64M |
| PreveCeutical Medical | 12.76M |
| Hemostemix | 12.69M |
| Rakovina Therapeutics | 12.04M |
| Britannia Life Sciences | 9.88M |
| Glow Lifetech | 7.70M |
| Marvel Biosciences | 7.58M |
| Kane Biotech | 6.15M |